Increased Expression of Fragile X Mental Retardation Protein in Malformative Lesions of Patients with Focal Cortical Dysplasia

Overview

Journal Neuroreport

Specialty Neurology

Date 2020 Aug 25

PMID 32833881

Citations 1

Authors

Conner D Reynolds

Suzanne O Nolan

Gregory D Smith

Taylor S Jefferson

Samantha L Hodges

Amy L Brewster

Joaquin N Lugo

Affiliations

Soon will be listed here.

Abstract

Objective: Focal cortical dysplasia (FCD) accounts for nearly half of all cases of medically refractory epilepsy in the pediatric and adult patient populations. This neurological disorder stems from localized malformations in cortical brain tissue due to impaired neuronal proliferation, differentiation, and migration patterns. Recent studies in animal models have highlighted the potential role of the Fragile X mental retardation protein (FMRP) levels in FCD. The purpose of this study was to investigate the status of FMRP activation in cortical brain tissues surgically resected from patients with FCD. In parallel, this study also investigated protein levels within the PI3K/AKT/mTOR and canonical Wnt signaling pathways.

Methods: Pathologic tissue from malformative lesions of FCD patients with medically refractory epilepsy was compared to relatively normal control non-epileptic tissue from patients with intracranial neoplasms. A series of western blotting assays were performed to assess key proteins in the PI3K/AKT/mTOR, canonical Wnt signaling pathways, and FMRP.

Results: There was suppression of S235/236-phosphorylated S6, GSK3α, and GSK3β protein levels in samples derived from FCD patients, compared to non-epileptic controls. FCD samples also had significantly greater levels of total and S499-phosphorylated FMRP.

Conclusion: These findings support our hypothesis that malformative lesions associated with FCD are characterized by high levels of FMRP activation along with dysregulation of both PI3K/AKT/mTOR and canonical Wnt signaling. These novel clinical findings extend previous work in animal models, further suggesting a potential unforeseen role of GSK3α and GSK3β in the pathophysiology of FCD and refractory epilepsy.

Citing Articles

Pathogenesis and Therapeutic Targets of Focal Cortical Dysplasia Based on Bioinformatics Analysis.

Kan Y, Feng L, Si Y, Zhou Z, Wang W, Yang J Neurochem Res. 2022; 47(11):3506-3521.

PMID: 35945307 DOI: 10.1007/s11064-022-03715-9.

References

La Fata G, Gartner A, Dominguez-Iturza N, Dresselaers T, Dawitz J, Poorthuis R . FMRP regulates multipolar to bipolar transition affecting neuronal migration and cortical circuitry. Nat Neurosci. 2014; 17(12):1693-700. DOI: 10.1038/nn.3870. View

Sharma A, Hoeffer C, Takayasu Y, Miyawaki T, McBride S, Klann E . Dysregulation of mTOR signaling in fragile X syndrome. J Neurosci. 2010; 30(2):694-702. PMC: 3665010. DOI: 10.1523/JNEUROSCI.3696-09.2010. View

Wyatt S, Witt T, Barbaro N, Cohen-Gadol A, Brewster A . Enhanced classical complement pathway activation and altered phagocytosis signaling molecules in human epilepsy. Exp Neurol. 2017; 295:184-193. DOI: 10.1016/j.expneurol.2017.06.009. View

Wang V, Chang E, Barbaro N . Focal cortical dysplasia: a review of pathological features, genetics, and surgical outcome. Neurosurg Focus. 2006; 20(1):E7. DOI: 10.3171/foc.2006.20.1.8. View

Hodges S, Reynolds C, Smith G, Jefferson T, Gao N, Morrison J . Neuronal subset-specific deletion of Pten results in aberrant Wnt signaling and memory impairments. Brain Res. 2018; 1699:100-106. DOI: 10.1016/j.brainres.2018.08.007. View

Reynolds C, Smith G, Jefferson T, Lugo J . Comparison of Equivalence between Two Commercially Available S499-Phosphorylated FMRP Antibodies in Mice. PLoS One. 2015; 10(11):e0143134. PMC: 4651511. DOI: 10.1371/journal.pone.0143134. View

Munji R, Choe Y, Li G, Siegenthaler J, Pleasure S . Wnt signaling regulates neuronal differentiation of cortical intermediate progenitors. J Neurosci. 2011; 31(5):1676-87. PMC: 3040956. DOI: 10.1523/JNEUROSCI.5404-10.2011. View

Lie D, Colamarino S, Song H, Desire L, Mira H, Consiglio A . Wnt signalling regulates adult hippocampal neurogenesis. Nature. 2005; 437(7063):1370-5. DOI: 10.1038/nature04108. View

Laggerbauer B, Ostareck D, Keidel E, Ostareck-Lederer A, Fischer U . Evidence that fragile X mental retardation protein is a negative regulator of translation. Hum Mol Genet. 2001; 10(4):329-38. DOI: 10.1093/hmg/10.4.329. View

10.

Cotter D, Honavar M, Lovestone S, Raymond L, Kerwin R, Anderton B . Disturbance of Notch-1 and Wnt signalling proteins in neuroglial balloon cells and abnormal large neurons in focal cortical dysplasia in human cortex. Acta Neuropathol. 1999; 98(5):465-72. DOI: 10.1007/s004010051111. View

11.

Baybis M, Yu J, Lee A, Golden J, Weiner H, McKhann 2nd G . mTOR cascade activation distinguishes tubers from focal cortical dysplasia. Ann Neurol. 2004; 56(4):478-87. DOI: 10.1002/ana.20211. View

12.

Ceman S, ODonnell W, Reed M, Patton S, Pohl J, Warren S . Phosphorylation influences the translation state of FMRP-associated polyribosomes. Hum Mol Genet. 2003; 12(24):3295-305. DOI: 10.1093/hmg/ddg350. View

13.

Nakashima M, Saitsu H, Takei N, Tohyama J, Kato M, Kitaura H . Somatic Mutations in the MTOR gene cause focal cortical dysplasia type IIb. Ann Neurol. 2015; 78(3):375-86. DOI: 10.1002/ana.24444. View

14.

Vezzani A, French J, Bartfai T, Baram T . The role of inflammation in epilepsy. Nat Rev Neurol. 2010; 7(1):31-40. PMC: 3378051. DOI: 10.1038/nrneurol.2010.178. View

15.

MacDonald B, Tamai K, He X . Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009; 17(1):9-26. PMC: 2861485. DOI: 10.1016/j.devcel.2009.06.016. View

16.

Luo Y, Shan G, Guo W, Smrt R, Johnson E, Li X . Fragile x mental retardation protein regulates proliferation and differentiation of adult neural stem/progenitor cells. PLoS Genet. 2010; 6(4):e1000898. PMC: 2851565. DOI: 10.1371/journal.pgen.1000898. View

17.

Seidenberg M, Pulsipher D, Hermann B . Association of epilepsy and comorbid conditions. Future Neurol. 2010; 4(5):663-668. PMC: 2802344. DOI: 10.2217/fnl.09.32. View

18.

Ljungberg M, Bhattacharjee M, Lu Y, Armstrong D, Yoshor D, Swann J . Activation of mammalian target of rapamycin in cytomegalic neurons of human cortical dysplasia. Ann Neurol. 2006; 60(4):420-9. DOI: 10.1002/ana.20949. View

19.

Helmstaedter C, Kockelmann E . Cognitive outcomes in patients with chronic temporal lobe epilepsy. Epilepsia. 2006; 47 Suppl 2:96-8. DOI: 10.1111/j.1528-1167.2006.00702.x. View

20.

Hagerman P, Stafstrom C . Origins of epilepsy in fragile X syndrome. Epilepsy Curr. 2009; 9(4):108-12. PMC: 2728488. DOI: 10.1111/j.1535-7511.2009.01309.x. View